Amorfix Life Sciences Ltd

(ARFXF)

By |

Profile

ProMIS Neurosciences Inc is a biotech company. It is focused on the discovery and development of precision medicine therapeutics for the treatment of neurodegenerative diseases, in particular, Alzheimer's disease and amyotrophic lateral sclerosis.

Contact Information

Website: www.promisneurosciences.com
Email: info@promisneurosciences.com
Main Phone: +1 415 341-5783
Address: 1920 Yonge Street
Address 2: Suite 200
State: ON
City / Town: Toronto
Country: CAN
Postal Code: M4S 3E2

Issuer Information

Exchange: OTCQB
CEO: Elliot Goldstein
Employees: 9
NAICS: Pharmaceutical Preparation Manufacturing (325412)
$ 0.28 $ 0.0092 (3.38%)
Last Price 0.28 Change $ 0.0092 Change % 3.38 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open 0.27 High 0.28 Low 0.27 Prev Close 0.27
Last Trade Volume 45,296 52 Wk Hi 0.70 52 Wk Low 0.14
Market Cap 69.2 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 245,794,697.00 EPS (TTM) N/A PE Ratio N/A Exchange OTCQB
Form Type Form Description Pages Date
D Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(6) under the Act 1 2018-05-03
D/A Amendment to a previously filed Form D 1 2017-09-11
D Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(6) under the Act 1 2017-08-18
D Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(6) under the Act 1 2017-03-27
D Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(6) under the Act 1 2017-03-08
D/A Amendment to a previously filed Form D 1 2016-11-22
D Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(6) under the Act 1 2016-09-22
D Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(6) under the Act 1 2016-08-24
D/A Amendment to a previously filed Form D 1 2016-06-15
D Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(6) under the Act 1 2016-04-14